Patent ID: 6919356
Filing Date: 2005-07-19
Classification: A61K,C07D

Abstract:
1. A compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein: Z is selected from O, S, N(R X is C(R R R R R R R R R R R R Y is selected from O, N(R ring B is a 5-7 membered cycloalkyl ring optionally containing a C═O, and being substituted with 0-2 R alternatively, ring B is a fused 5-7 membered saturated heterocyclic ring containing 0-1 O, N(R provided that if ring B is a heterocyclic ring, then the number of carbon atoms separating the heteroatom of ring B and the nitrogen atom of structure (I) bonded to R R R R R R R R R R R R R R R R R alternatively, R R R R R R R R R R alternatively, R R R′, at each occurrence, is independently selected from H, C R R R R R R R R R R R R R R R R alternatively, R R i is selected from 0, 1, and 2; m is selected from 0, 1, and 2; s is selected from 0 and 1; with the proviso: m+s is selected from 0, 1, and 2; v is selected from 0, 1, 2, and 3; with the proviso: that the total number of atoms between the nitrogen of which R′ is attached and the fused ring B is less than or equal to 4; r is selected from 0, 1, 2, 3, 4, and 5; t is selected from 0, 1, 2, 3, 4, and 5; q is selected from 1, 2, 3, 4, and 5; p is selected from 1, 2, and 3; u is selected from 0, 1 and, 2.